Clinical Trial

First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors

Name: First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors — clinical trial record (NCT07265622)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is the first-in-human study of 7MW4911 in Chinese patients, to investigate its prelimary safety and efficacy in patients with Advanced Solid Tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-03.

Trial Details

NCT Number	NCT07265622
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	Solid Tumors
Enrollment	200 participants
Start Date	2025-11-12
Primary Completion	2027-07 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-12-29